- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03244748
Amiodarone Usage After Ischemic Ventricular Tachycardia Ablation
Effect of Amiodarone After Ischemic Ventricular Tachycardia Ablation
Study Overview
Status
Intervention / Treatment
Detailed Description
Ischemic cardiomyopathy patients have implantable cardioverter defibrillators (ICD) to prevent arrhythmic deaths. Ventricular tachycardia (VT) events with frequent ICD interventions in ischemic cardiomyopathy patients is encountered frequently. Frequents ICD interventions is associated with worse outcomes. Anti-arrhythmic drugs ,mostly amiodarone, are given prevent ventricular arrhythmias and ICD interventions that may not be curative. Ablation of ventricular tachycardia is the suggested treatment when anti-drugs are without effect. After ablation of ventricular arrhythmia the continuation of amiodarone is not well elucidated.
In this study we aimed to enroll ischemic cardiomyopathy patients having frequent ICD interventions despite medical treatment. VT ablation is performed and patients divided into two groups; group one continues having amiodarone after ablation, group two does not have amiodarone after ablation. Both groups will be compared in terms of recurrence and death.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
-
Ankara, Turkey, 06590
- Recruiting
- Turkiye Yuksek Ihtisas Training and Research Hospital
-
Contact:
- Firat Ozcan, Ass. Prof, MD
- Phone Number: 5327854000
- Email: drfozcan@gmail.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
Ischemic cardiomyopathy patients applied with frequent ICD interventionor electrical storms and having ejection fraction below 50%. Frequent ICD defined as more than 1 ICD intervention within month. Electrical storm defined as more than 2 ICD intervention within one day.
Exclusion Criteria:
Patients with cardiomyopathies other than ischemic etiology
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Group 1
Patients underwent ablation and continued having amiodarone after the procedure
|
Electrophysiologic procedure aims to ablate and terminate arrhythmia percutaneously
|
Group 2
Patients underwent ablation and not having amiodarone after the procedure
|
Electrophysiologic procedure aims to ablate and terminate arrhythmia percutaneously
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Major adverse cardiovascular events
Time Frame: six months
|
Death, ICD intervetion
|
six months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Firat Ozcan, MD, MD
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ozcan01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ventricular Tachycardia
-
University of PretoriaCompletedSupra-ventricular TachycardiaSouth Africa
-
Ottawa Heart Institute Research CorporationNot yet recruitingVentricular Fibrillation | Ventricular Tachycardia | Ventricular Arrhythmias | Recurrent Ventricular Tachycardia
-
Armgo Pharma, Inc.Food and Drug Administration (FDA)RecruitingCatecholaminergic Polymorphic Ventricular Tachycardia Type 1United States, Netherlands
-
Adagio MedicalActive, not recruitingMonomorphic Ventricular TachycardiaNetherlands, Czechia, Canada, Belgium, France, Germany
-
John SappCanadian Institutes of Health Research (CIHR); Nova Scotia Health Authority; Abbott... and other collaboratorsActive, not recruitingVentricular Tachycardia (VT)Canada, United States, France
-
John SappCanadian Institutes of Health Research (CIHR); Abbott Medical Devices; Biosense...CompletedRecurrent Ventricular TachycardiaCanada
-
Fundación Hospital de MadridCompletedSustained Monomorphic Ventricular TachycardiaSpain
-
University of Turin, ItalyAzienda Unità Sanitaria Locale Reggio Emilia; IRCCS Sacro Cuore Don Calabria... and other collaboratorsRecruitingRefractory Ventricular TachycardiaItaly
-
Thermedical, Inc.Not yet recruitingRefractory Ventricular TachycardiaUnited States, Canada
-
John SappCompleted
Clinical Trials on Ventricular tachycardia ablation
-
IRCCS San RaffaeleUnknownVentricular TachycardiasBelgium, Czechia, France, Germany, Italy, Portugal, Switzerland
-
Rush University Medical CenterMedical University of South Carolina; University of Michigan; The Cleveland Clinic and other collaboratorsNot yet recruitingVentricular Tachycardia | Ischemic CardiomyopathyUnited States
-
Central Hospital, Nancy, FranceRecruitingVentricular Tachycardia | Ischemic CardiomyopathyFrance
-
University Hospital, ToulouseUnknownVentricular TachycardiaFrance
-
Spyridon DeftereosBiosense Webster, Inc.UnknownMyocardial Infarction | Heart Failure | Ventricular Tachycardia
-
Centro Medico TeknonRecruitingMyocardial Infarction | Ischemic Heart Disease | Ventricular Tachycardia | Magnetic Resonance Imaging | Ventricular Arrythmia | Sudden Cardiac Death | Sudden Cardiac Death Due to Cardiac ArrhythmiaSpain
-
Hacettepe UniversityCompleted
-
Oxford University Hospitals NHS TrustCompletedHeart Failure | Atrial Fibrillation | Ventricular TachycardiaUnited Kingdom
-
University Medical Centre LjubljanaCompletedVentricular Tachycardia | Ischemic CardiomyopathySlovenia, Croatia
-
Liverpool Heart and Chest Hospital NHS Foundation...Newcastle-upon-Tyne Hospitals NHS Trust; Imperial College Healthcare NHS TrustNot yet recruiting